Altered <scp>BCR</scp> and <scp>CD</scp>40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients
Egil Støre Blix(University Hospital of North Norway), Arne Kolstad(Oslo University Hospital), Anne Husebekk(UiT The Arctic University of Norway), June H. Myklebust(Oslo University Hospital), Jan Delabie, Jonathan M. Irish(Vanderbilt University), Anne Tierens(University Health Network)
Cited by 7
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Oncogenically active MYD88 mutations in human lymphoma
|Nature|2010|1.5k